Johnson & Johnson Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine

New Brunswick, N.J., August 05, 2020 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational vaccine, Ad26.COV2.S, for use in the United States following approval or Emergency Use Authorization by the U.S. Food and Drug Administration (FDA). The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response, in collaboration with the U.S. Department of Defense, is committing over $1 billion for this agreement. The vaccine will be provided at a global not-for-profit basis for emergency pandemic use. The U.S. government may also purchase an additional 200 million doses of Ad26.COV2.S under a subsequent agreement. “Johnson &Johnson’s global team of experts has worked tirelessly alongside BARDA and scientific partners to pursue a SARS-CoV-2 vaccine that can help to stop the spread of COVID-19. We greatly appreciate the U.S. government’s confidence in, and support for, our R&D platform and efforts and the scalability of our vaccine technology. We are scaling up production in the U.S. and worldwide to deliver a SARS-CoV-2 vaccine for emergency use,” said Paul Stoffels, M.D., Vice Chairman ...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news

Related Links:

With negotiations over COVID-19 pandemic relief stalled, lawmakers are looking to pass a stopgap funding bill to keep the government operational in the new fiscal year which starts on October 1. A stopgap funding measure is required because the House and Senate have not yet agreed on and passed appropriations bills to fund the government in fiscal year 2021. After House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin reached an agreement to pursue a clean short-term spending bill earlier this month, the House passed a bipartisan continuing resolution on September 22 extending federal funding through Dece...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
According to a new report from the National Academies of Sciences, Engineering, and Medicine (NASEM), biological collections - living and natural history specimens, biological materials, and data in museums, stock centers, research centers, and universities - are in need of long-term financial sustainability, digitization, recruitment and support of a diverse workforce, and infrastructure upgrades. The report, Biological Collections: Ensuring Critical Research and Education for the 21st Century, which was sponsored by the National Science Foundation (NSF), argues that biological collections are an “invaluable, and ...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
The World Health Organization (WHO) has released a preliminary framework for the global allocation of COVID-19 vaccines when they become available. The plan is intended to guide policymakers at the global, regional, and national level in their allocation and prioritization decisions about vaccines. WHO’s “fair allocation mechanism” emphasizes equitable allocation of vaccines and lists groups of people that should have priority access. The plan proposes vaccine distribution in two phases. In the first phase, all countries would receive vaccine doses in proportion to their population size - initially enoug...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
Enter the Faces of Biology Photo Contest for your chance to win $250 and to have your photo appear on the cover of the journal BioScience. The competition, sponsored by the American Institute of Biological Sciences (AIBS), recognizes scientists who use imagery to communicate aspects of biological research to the public and policymakers. The theme of the contest is “Faces of Biology.” Photographs entered into the contest must depict a person, such as a scientist, researcher, collections curator, technician, or student, engaging in biological research. The depicted research may occur outside, in a lab, with a n...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
Members of the House Science, Space, and Technology Committee, led by Chairwoman Eddie Bernice Johnson (D-TX), have introduced bipartisan legislation to create a new postdoctoral fellowship program at the National Science Foundation (NSF) to help keep early career researchers whose employment opportunities have been impacted by the COVID-19 pandemic in the STEM pipeline. "I am deeply concerned about the disappearance of STEM job opportunities and the potential long-term consequences for our STEM pipeline," stated Chairwoman Johnson. "For established researchers, the COVID-19 crisis has severely limited their...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
WHO says global toll is likely tobe over one million already; travel in and out of Amsterdam, Rotterdam and The Haguemay be bannedTests that give results in minutes to be rolled out across worldCDC director takes aim at Trump adviser: ‘Everything he says is false’Crew on first post-lockdown Greek cruise contract coronavirus7.45pmBSTMEPs won ’t yet be returning to Strasbourg due to rising coronavirus infections in France, the European parliament speaker said, despite a plea by president Emmanuel Macron.The parliament has its headquarters in Strasbourg in eastern France, where MEPs usually based in Brussels...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak World news Australia news UK news US news Science Infectious diseases Source Type: news
There is a small chance that Pfizer's vaccine trial will yield results by Nov. 3. Here's everything that has to happen and how to tell a political stunt from a real vaccine.ProPublica
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Public Health & Prevention News Source Type: news
Rapidly deployable community isolation facilities have proven effective for managing the COVID-19 pandemic in Singapore, according to a new report.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Most commercial serological assays accurately detect anti-SARS-CoV-2 antibodies in patients who have recovered from COVID-19, according to a comparative study of 10 assays.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Two former heads of a Massachusetts veterans home have been indicted on criminal neglect charges for their roles in handling a COVID-19 outbreak that killed 76 people, the state's attorney general said on Friday.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
More News: Allergy & Immunology | Belgium Health | Brain | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | COVID-19 | Department of Health | Ebola | Ebola Vaccine | Emergency Medicine | Environmental Health | Food and Drug Administration (FDA) | Government | Health Management | Heart | Hypertension | Infectious Diseases | Learning | Legislation | Neurology | Neuroscience | Pandemics | Pharmaceuticals | Profits and Losses | Pulmonary Hypertension | SARS | Science | Universities & Medical Training | USA Health | Vaccines | Zika Virus